Publication | Closed Access

Discovery of pyrrolospirooxindole derivatives as novel cyclin dependent kinase 4 (CDK4) inhibitors by catalyst-free, green approach

Combinatorial ChemistryMedicinal ChemistryGreen ApproachHeterocyclicBiochemistryPyrrolospirooxindole DerivativesNatural SciencesMedicineOrganic ChemistryHeterocycle ChemistryPharmacologyPharmaceutical ChemistryDrug Discovery